As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...

Catalyst Pharma ( ($CPRX) ) has shared an announcement. On August 25, 2025, Catalyst Pharmaceuticals and its licensor SERB S.A. announced a ...

The following is a listing of all home transfers in Burlington County reported from Aug. 18 to Aug. 24. There were 114 ...

Catalyst Pharmaceuticals ( NASDAQ: CPRX) said that the company and licensor SERB S.A. signed a settlement agreement with ...

Catalyst Pharmaceuticals agreed to settle its litigation against Lupin Pharmaceuticals over Lupin's application to market a generic version of Catalyst's Lambert-Eaton myasthenic syndrome drug.

Entrepreneurship competition draws over 50,000 applicants each season, culminating in high-stakes outcomes such as 'Most ...

Catalyst Pharmaceuticals (CPRX) announced that the Company and its licensor SERB S.A. have entered into a Settlement Agreement with Lupin Ltd and ...

As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst ...

RBI Governor Sanjay Malhotra expressed hope that India-US trade talks will reach a positive conclusion. Malhotra's remarks come at a time when the sixth round of India-US Bilateral Trade Agreement ...

Zee Business Managing Editor Anil Singhvi shares his strategy for the coming session on Dalal Street. Learn more about his ...